Abingworth as of Dec. 31, 2015
Portfolio Holdings for Abingworth
Abingworth holds 18 positions in its portfolio as reported in the December 2015 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Chiasma | 24.6 | $41M | 2.1M | 19.56 | |
| Proteon Therapeutics | 18.9 | $31M | 2.0M | 15.50 | |
| Paratek Pharmaceuticals | 14.9 | $25M | 1.3M | 18.97 | |
| Sientra | 7.9 | $13M | 2.2M | 5.92 | |
| Cempra | 7.2 | $12M | 384k | 31.12 | |
| Dicerna Pharmaceuticals | 6.8 | $11M | 946k | 11.87 | |
| Tobira Therapeutics Inc Common Stock Usd 0.0001 | 3.6 | $5.9M | 589k | 10.01 | |
| Lombard Med (EVARF) | 2.7 | $4.4M | 3.5M | 1.28 | |
| Innocoll | 2.5 | $4.2M | 556k | 7.52 | |
| Cellectis S A (CLLS) | 1.9 | $3.1M | 100k | 31.00 | |
| Adaptimmune Therapeutics (ADAP) | 1.8 | $3.0M | 250k | 12.05 | |
| Regulus Therapeutics | 1.7 | $2.9M | 327k | 8.71 | |
| Cymabay Therapeutics | 1.6 | $2.7M | 1.6M | 1.67 | |
| Dermira | 1.5 | $2.4M | 70k | 34.56 | |
| Anthera Pharmaceutcls | 1.2 | $2.0M | 438k | 4.64 | |
| Chemocentryx | 1.1 | $1.7M | 215k | 8.09 | |
| OncoGenex Pharmaceuticals | 0.3 | $475k | 396k | 1.20 | |
| Epirus Biopharmaceuticals In (EPRSQ) | 0.0 | $24k | 7.9k | 3.04 |
